Jan Hermansson
Technik-/Wissenschafts-/F&E-Leiter bei CHORDATE MEDICAL HOLDING AB
Profil
Jan Hermansson is currently the CSO and Director of Clinical Research & Medical at Chordate Medical Holding AB since 2012.
Prior to this, he worked as the Head of Division at AstraZeneca AB from 2001 to 2010 and as the Vice President of Therapeutic Area at Pharmacia & Upjohn, Inc. from 1998 to 2001.
Dr. Hermansson received his doctorate degree from Karolinska Institutet in 1980.
Aktive Positionen von Jan Hermansson
| Unternehmen | Position | Beginn |
|---|---|---|
| CHORDATE MEDICAL HOLDING AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Ehemalige bekannte Positionen von Jan Hermansson
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01.01.2010 |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Jan Hermansson
| Karolinska Institutet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHORDATE MEDICAL HOLDING AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
